Ottawa, August 21, 2007 ... Medtronic Inc., wishes to conduct a search for an outsource manufacturing partner in Canada with a strategic match with its business needs.
Medtronic, Inc. (MDT (NYSE), headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world. Each year, 5 million patients benefit from Medtronic's technology, used to treat conditions such as diabetes, heart disease, neurological disorders, and vascular illnesses. Medtronic does business in more than 120 countries and employs more than 37,000 people worldwide.
One of six Medtronic's business divisions, CRM is responsible for $6 billion of Medtronic's $12 billion annual revenues. CRM wishes to identify a potential outsource manufacturing partner in Canada for the production of pacing leads.
A pacing lead relays a pacing pulse from a pacemaker or implanted defibrillator to the heart. The lead may also relay information about the heart’s electrical activity back to the implanted device. Medtronic (www.medtronic.com) offers many different pacing lead models, some delivering active ingredients (drugs). A physician will choose a lead that fits the needs of an individual’s body: the size and structure of veins and the heart’s size, structure, and muscular condition.
Additional information on the company is available at http://www.medtronic.com/
Given the medical/legal liability issues involved and quality assurance requirements of the implanted medical devices with drug delivery capabilities, the ideal Canadian outsourcing partner must have a demonstrated track record in drug/medical device manufacturing (experience), is cGMP compliant (quality assurance), has polymer molding knowledge, preferably has an FDA registration and the capacity to produce approximately 1-2 million molded pacing lead components per year,
The Canadian outsource medical device or drug manufacturers will have the requisite combination of polymer and drug/pharmaceutical manufacturing experience, quality assurance and compliance certification and capabilities to produce large quantities of proprietary Medtronic pacing lead(s).
All expressions of interest must be submitted by September 22nd, 2007, 17:00 EST by email to Muriel Debroy
++ Action Item:
Companies wishing to participate in the CATA Supply Chain and Partnership Outreach Program (similar to Medtronic and Lockheed Martin) should contact CATA President John Reid at 613-236-6550 ext 224.